Lung diseases in the rheumatic diseases can present in protean fashion, involving the airway, pleura and the parenchyma and these can lead to significant morbidity and mortality. The rheumatologist must be cognizant of these complications and facile with both timely diagnosis and treatment. In addition, the rheumatologist must be prepared to work closely with pulmonary specialists to deal with rheumatic disease patients with pulmonary complications and those patients where pulmonary disease represents the primary and sometimes initial manifestation of a systemic autoimmune disease.
Upon completion of this session, participants should be able to:
- identify emerging concepts regarding the pathophysiology of inflammation and fibrosis in autoimmune lung disease
- recognize the appropriate use of diagnostic tests in the evaluation of patients with rheumatic disorders and autoimmune lung disease
- discuss the limits of traditional therapeutic options and possible emerging therapies in managing autoimmune lung disease
To see other sessions for this day, use the date buttons to the left.